Review: Tricyclic and tetracyclic antidepressants are moderately effective for reducing chronic low-back pain

Underwood, Martin
July 2004
ACP Journal Club;Jul/Aug2004, Vol. 141 Issue 1, p13
Academic Journal
Tricyclic and tetracyclic antidepressants are moderately effective for reducing chronic low-back pain. Studies with insufficient data to assess treatment response were excluded. Methodological quality was assessed using a 22-point scale based on the 19-point criteria developed by the Cochrane Collaboration Back Review Group. Tricyclic or tetracyclic antidepressants are moderately effective for reducing pain in patients with chronic low-back pain. Antidepressants that do not inhibit norepinephrine reuptake show no benefit for pain relief or functional status. Although antidepressants are helpful for several painful conditions, their effectiveness for CLBP has been unclear.


Related Articles

  • Discontinuation of Use and Switching of Antidepressants. Bull, Scott A.; Hu, X. Henry; Hunkeler, Enid M.; Lee, Janelle Y.; Ming, Eileen E.; Markson, Leona E.; Fireman, Bruce // JAMA: Journal of the American Medical Association;9/18/2002, Vol. 288 Issue 11, p1403 

    Presents a study to investigate the relationship between patient-physician communication and the continuation of treatment with antidepressants. Exploration of the demographics, adverse effects, therapeutic response, and frequency of follow-up visits; Design, setting, and patients; Main outcome...

  • Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine. Owens, Michael J.; Krulewicz, Stan; Simon, Jeffrey S.; Sheehan, David V.; Thase, Michael E.; Carpenter, David J.; Plott, Susan J.; Nemeroff, Charles B. // Neuropsychopharmacology;Dec2008, Vol. 33 Issue 13, p3201 

    Paroxetine and venlafaxine are potent serotonin transporter (SERT) antagonists and weaker norepinephrine transporter (NET) antagonists. However, the relative magnitude of effect at each of these sites during treatment is unknown. Using a novel blood assay that estimates CNS transporter occupancy...

  • Cost-Effectiveness of Depressive Episode Pharmacological Treatment. Rančić, Nemanja K.; Djuričić, Katarina D. Nikić; Mihajlović, Goran S.; Yamada Tetsuji; Janković, Slobodan M.; Stevanović, Dejan S.; Jovanović, Mirjana R.; Biorac, Nenad M.; Chen Chia Ching; Jakovljević, Mihajlo B.; Savić, Dejana M. // Hospital Pharmacology: International Multidisciplinary Journal;2015, Vol. 2 Issue 1, p235 

    Background and Objectives There is a paucity of published cost-effectiveness studies of alternative scenarios in depressive episode acute medical care in Eastern European populations. Methods Prospective cost-effectiveness analysis was conducted on 65 depressive patients in a large university...

  • A selective norepinephrine reuptake inhibitor for the treatment of major depression. Gutierrez; Stimmel, Mary A. // Formulary;Nov99, Vol. 34 Issue 11, p909 

    Reboxetine is the first of a new class of drugs known as selective norepinephrine reuptake inhibitors for the treatment of major depression. It is expected to be launched at the end of 1999. Comparative clinical trials show reboxetine to be as effective as imipramine and desipramine in adults...

  • DEMENTIA-RELATED BEHAVIOR MANAGEMENT. Coggins, Mark D. // Aging Well;Jan/Feb2012, Vol. 5 Issue 1, p32 

    The article offers information on the treatment and management of reversible dementia, which is commonly induced by medication, depression, and other diseases in older people. It states that the most common type of reversible dementia is Alzheimer's disease (AD), wherein, patients develop...

  • Effects of Two 4-Week Proprioceptive Neuromuscular Facilitation Programs on Muscle Endurance, Flexibility, and Functional Performance in Women With Chronic Low Back Pain. Kofotolis, Nick; Kellis, Eleftherios // Physical Therapy;Jul2006, Vol. 86 Issue 7, p1001 

    Background and Purpose. Improving functional performance in patients with chronic low back pain is of primary importance. The purpose of this study was to examine the effects of 2 pr.oprioceptive neuromuscular facilitation (PNF) programs on trunk muscle endurance, flexibility, and functional...

  • The Impact of the Type of Insurance Plan on Adherence and Persistence With Antidepressants: A Matched Cohort Study. Assayag, Jonathan; Forget, Amélie; Kettani, Fatima-Zohra; Beauchesne, Marie-France; Moisan, Jocelyne; Blais, Lucie // Canadian Journal of Psychiatry;Apr2013, Vol. 58 Issue 4, p233 

    Objective: To compare adherence to, and persistence with, antidepressants (AD) in Quebec patients who are covered by private and public drug insurance. Methods: A matched cohort study was conducted using prescription claims databases: reMed, a medication data registry for Quebec residents...

  • Efficacy and tolerability of agomelatine in the treatment of depression. Plesničar, Blanka Kores // Patient Preference & Adherence;2014, Vol. 8, p603 

    Depression is a severe and usually recurrent mental disorder which often leads to a significant impairment of everyday functioning, a reduced quality of life, and also great suffering of the patients. The treatment of a depressive disorder is not only limited to acute treatment; it also requires...

  • Treating Depression in Patients with Ischaemic Heart Disease: Which Agents are Best to Use and to Avoid? Roose, S.P.; Spatz, E. // Drug Safety;May1999, Vol. 20 Issue 5, p459 

    There are a number of dimensions to the complex relationship between cardiovascular disease and affective disorders including: patients with depression are at an increased risk of dying from sudden cardiovascular death compared with the general population; patients with depression over the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics